Latest Placebo-controlled study Stories
-- Primary endpoint was met for 50 mg twice daily dosing -- FREMONT, Calif., Oct. 1, 2014 /PRNewswire/ -- Ardelyx, Inc.
PLANTATION, Fla., July 29, 2014 /PRNewswire/ -- Neurotrope, Inc.
Treatment with VGX-3100 induces regression of precancerous cervical disease and clears HPV infection with robust T cell responses PLYMOUTH MEETING, Pa., July 23, 2014 /PRNewswire/
ADYX-003, Randomized, Placebo-Controlled Study to Evaluate Safety and Efficacy of Two Dose-Volume Levels of AYX1 for the Prevention of Pain Following Total Knee Replacement SAN FRANCISCO,
Avail is conducting a Phase 2, randomized, placebo-controlled clinical research study to evaluate the efficacy, safety and pharmacokinetics of an experimental spray treatment for qualified participants
- TAS-102 demonstrated a statistically significant improvement in overall survival and progression-free survival - BARCELONA, Spain and PRINCETON, N.J., June 28, 2014 /PRNewswire/
KANSAS CITY, Kan., June 18, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics
MOMENCE, Ill., June 17, 2014 /PRNewswire/ -- FutureCeuticals, Inc.
Previously released interim results from the trial showed positive safety and efficacy; 300 patients with moderate to severe disease were enrolled in the study PETACH TIKVA, Israel,
- an ornament or knob in the shape of a flower